Dr. Vinay Prasad succeeds Dr. Peter Marks, who left the role of leader of the FDA’s Center for Biologics Evaluation and ...

The Food and Drug Administration says that a prominent medical contrarian and critic of the drug industry will head its ...

The new vaccine chief of the Food and Drug Administration is, perhaps not surprisingly, a doctor well-known for his ...

The Food and Drug Administration (FDA) has tapped Vinay Prasad, a prominent critic of federal COVID-19 policies and a ...

The Food and Drug Administration announced Tuesday it has picked a new head of its center charged with vaccine approvals and other biologics products: Dr. Vinay Prasad, a vocal critic of the agency's ...

A spokesperson for Moderna said the company has run clinical trials for its booster shots before and after their launch. During an earnings call Thursday, president Stephen Hoge said the company ...

The UK has become the first country in the world to authorise an updated COVID-19 booster vaccine directed at the Omicron variant, giving a green light to Moderna's mRNA-1273.214 shot.

At the moment only Pfizer/BioNTech's Comirnaty vaccine has been approved by the FDA for booster use, but a decision by the agency is expected in the coming days for the Moderna and J&J jabs.

Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.

On a Thursday conference call with investors, Moderna CFO Jamey Mock outlined a roadmap for the mRNA specialist to lower its ...

Moderna's cost-cutting drives better-than-expected results Combination COVID and flu shot approval not expected until 2026 Tariffs have minimal impact on Moderna's U.S.-manufactured drugs May 1 ...